Non-anti Thymocyte Globulin regimens for peripheral blood allogenic stem cell transplantation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Non-anti Thymocyte Globulin regimens for peripheral blood allogenic stem cell transplantation, covering 2018-11-27 to 2018-11-27. Get the full timeline:
Most recent: Clinical Trial Update: Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients [Phase 2, Phase 3]